Akari Therapeutics (AKTX) Market Cap to FCF (2015 - 2026)

Akari Therapeutics (AKTX) Market Cap to FCF (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Market Cap to FCF
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -5.64 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -3.06 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -33,454.81
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -8,971.08
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -120,325.05
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 30.95
9 Abivax 91.96 Bn 91.96 Bn - -620.37
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 15.42

Historic Data

Download Data
DateValue
Jun 18, 2026 -120,325.05
Jun 17, 2026 -134,263.15
Jun 16, 2026 -141,558.88
Jun 15, 2026 -139,381.06
Jun 12, 2026 -151,359.11
Jun 11, 2026 -160,070.43
Jun 10, 2026 -159,308.19
Jun 9, 2026 -158,437.06
Jun 8, 2026 -169,108.42
Jun 5, 2026 -164,099.41
Jun 4, 2026 -172,484.06
Jun 3, 2026 -163,173.83
Jun 2, 2026 -156,662.13
Jun 1, 2026 -149,997.97
May 29, 2026 -178,908.65
May 28, 2026 -240,105.63
May 27, 2026 -173,409.63
May 26, 2026 -184,788.78
May 22, 2026 -198,944.68
May 21, 2026 -55,534.64